9/9 Lecture

Course Logistics and Examination Procedures

• Friday Q&A Session Details:

  • Friday sessions function as a voluntary Question & Answer (Q&A) period.

  • Attendance is optional for students who have reviewed all course material, have no remaining questions, and prefer self-directed study.

  • Q&A sessions and examination days strictly commence at $11:00\,\text{AM}$ to maximize available working time.

  • Arriving late with less than $15\,\text{minutes}$ remaining during a Q&A session severely limits the utility of any example problems put up on the board.

• Final Examination and Classroom Protocol:

  • The cumulative ending examination takes place on Monday.

  • Due to consecutive class sections scheduled back-to-back in the room, time limits are strictly enforced. Time will be called promptly at the conclusion of the section period.

  • Exams must be submitted immediately upon the call of time; unsubmitted exams will be collected directly from students to permit the entry of the subsequent section.

  • Students leaving the classroom must gather their belongings and exit immediately without holding conversations inside or directly outside the room to accommodate waiting students.

Myoglobin Oxygen Binding Mechanics

• Gas Pressure and Ligand Concentration:

  • Oxygen binding curves for myoglobin and hemoglobin display pressure ($\text{Pascals}$ or kilopascals, $\text{kPa}$) along the x-axis rather than standard molar concentration because oxygen is a gas.

  • An increase in partial pressure pushes a greater volume of gas into the aqueous liquid phase, making partial pressure functionally equivalent to increasing ligand concentration on the x-axis.

• Physiological Oxygen Pressures:

  • Partial pressure of oxygen in human lungs: approximately $13\,\text{kPa}$.

  • Partial pressure of oxygen in peripheral tissue sites: approximately $4\,\text{kPa}$.

• Myoglobin Fractional Saturation and Transport Inefficiency:

  • Fractional saturation ($Y$) measures the proportion of total ligand-binding sites occupied by oxygen.

  • At lung oxygen pressure ($13\,\text{kPa}$), myoglobin reaches near-complete oxygen saturation.

  • At tissue oxygen pressure ($4\,\text{kPa}$), myoglobin maintains a fractional saturation of $95\%$ ($0.95$).

  • Because myoglobin retains $95\%$ of its bound oxygen at $4\,\text{kPa}$, it fails to release oxygen under normal physiological conditions, making it an ineffective oxygen transport protein.

• Physiological Role of Myoglobin:

  • Myoglobin functions primarily as an emergency oxygen storage battery or backup reservoir rather than a transport vehicle.

  • It retains bound oxygen tightly during normal resting conditions and only releases $O_2$ when tissue oxygen levels drop extremely low, such as during severe hypoxia or intense strenuous exercise.

Pharmacological Ligand Binding and Curve Analysis

• Pharmaceuticals as Ligands:

  • Prescription medications, antibiotics, allergy treatments, and non-steroidal anti-inflammatory drugs (NSAIDs) act as small-molecule ligands that target specific cellular receptors or proteins.

  • Pharmacological research utilizes ligand binding curves to assess binding affinity across prospective drug candidates.

• Left-Shifting vs. Right-Shifting of Binding Curves:

  • Left-Shift: Indicates an increase in binding affinity (tighter, stronger binding). A left-shifted candidate (e.g., candidate $A$ relative to candidate $B$) achieves receptor saturation at lower ligand concentrations.

  • Right-Shift: Indicates a decrease in binding affinity (weaker binding). A right-shifted candidate requires higher concentrations to achieve equivalent receptor occupancy.

  • Binding curves establish baseline parameters for therapeutic dosing strategies by determining whether target activation requires full saturation or $50\%$ receptor occupancy.

• Pharmacological Terminology:

  • Agonist: A small molecule or compound that binds to a receptor, activates it, and triggers a downstream biological response.

  • Antagonist: A compound that binds to a receptor to prevent activation or block a biological response.

Hemoglobin Quaternary Structure and Conformational States

• Structural Comparison of Myoglobin and Hemoglobin:

  • Myoglobin: Monomeric protein consisting of a single polypeptide chain rich in $\alpha$-helices and containing a single heme prosthetic group that binds one molecule of $O_2$.

  • Hemoglobin: Tetrameric protein complex ($\alpha_2\beta_2$) composed of four total polypeptide chains: two identical $\alpha$-subunits and two identical $\beta$-subunits. Each of the four individual subunits contains its own heme group, allowing a complete hemoglobin molecule to bind up to four $O_2$ molecules.

• Conformational States (Induced Fit Mechanism):

  • T State (Tense State):

    • Characterized by a more rigid quaternary structure stabilized by an increased number of ionic interactions (salt bridges).

    • Represents the dominant structure of the unliganded/deoxy form (deoxyhemoglobin).

    • Exhibits a significantly lower affinity for oxygen.

  • R State (Relaxed State):

    • Characterized by a more flexible quaternary structure resulting from the disruption/breaking of salt bridges.

    • Represents the dominant structure of the fully oxygenated form (oxyhemoglobin).

    • Exhibits a significantly higher affinity for oxygen.

• Structural Movements Upon Oxygen Binding:

  • In the unliganded T state, the iron-bound heme ring is non-planar (slightly bent or puckered).

  • Oxygen binding pulls the iron atom into the plane of the porphyrin ring, forcing the heme group to adopt a planar geometry.

  • This localized movement causes subtle shifts in adjacent $\alpha$-helices (bringing specific helices closer together and altering their spatial arrangement).

  • Because the four subunits are tightly packed, structural changes at one subunit physically push against neighboring subunits, driving the quaternary structural transition from the T state to the R state.

Mechanisms and Models of Cooperativity

• Cooperativity Principles:

  • Cooperativity occurs in proteins with multiple binding sites when ligand binding at one site influences the binding affinity of remaining vacant sites.

  • Positive Cooperativity: Ligand binding at one site increases the binding affinity of subsequent sites.

  • Negative Cooperativity: Ligand binding at one site decreases the binding affinity of subsequent sites.

  • Non-cooperative systems possess multiple sites that bind ligands independently without mutual structural influence.

• Concerted Model (MWC Model) vs. Sequential Model (KNF Model):

  • Concerted Model:

    • Dictates that all subunits within the protein complex must exist in the exact same conformational state simultaneously (all subunits are all-T or all-R).

    • An equilibrium exists between the unliganded T state (preferred due to stabilizing salt bridges) and the unliganded R state.

    • Ligand binding to a subunit in the R state traps the complex in R, shifting the overall population equilibrium toward the high-affinity R state and facilitating subsequent ligand binding.

  • Sequential Model:

    • Allows individual subunits to undergo independent conformational changes upon ligand binding.

    • Binding of a ligand to one subunit induces a local structural change that incrementally alters adjacent subunits, progressively increasing their affinity without requiring a simultaneous, all-or-none transition of the entire complex.

Quantitative Comparison of Oxygen Transport Efficiency

• Binding Curve Morphology:

  • Myoglobin Curve: Displays a hyperbolic shape characteristic of single-site non-cooperative binding.

  • Hemoglobin Curve: Displays a sigmoidal (S-shaped) curve characteristic of positive cooperative binding across multiple sites.

• Comparative Oxygen Delivery Dynamics:

  • High-Affinity Monomeric State (Myoglobin):

    • Lung saturation ($13\,\text{kPa}$): $\approx 98\%$

    • Tissue saturation ($4\,\text{kPa}$): $\approx 95\%$

    • Net oxygen delivery fraction: $98\% - 95\% = 3\%$

  • Hypothetical Constant Low-Affinity State:

    • Lung saturation ($13\,\text{kPa}$): $\approx 45\%$

    • Tissue saturation ($4\,\text{kPa}$): $\approx 20\%$

    • Net oxygen delivery fraction: $45\% - 20\% = 25\%$

  • Cooperative Tetrameric State (Hemoglobin):

    • Lung saturation ($13\,\text{kPa}$): $\approx 95\%\text{--}98\%$

    • Tissue saturation ($4\,\text{kPa}$): $\approx 60\%$

    • Net oxygen delivery fraction: $98\% - 60\% = 38\%$ (approximated as $40\%$ delivery under normal physiological conditions).

Allosteric Regulation: Protons and Carbon Dioxide

• Allosteric Terminology:

  • Allosteric Protein: A protein whose binding properties at its primary site are altered by the binding of a regulatory molecule at a distinct (allosteric) site.

  • Homotropic Effector: An allosteric regulator that is identical to the primary ligand ($O_2$ binding to one subunit acting as a positive homotropic effector for adjacent subunits).

  • Heterotropic Effector: An allosteric regulator that is a distinct, non-ligand molecule ($H^+$, $CO_2$, BPG).

• Proton Regulation (Bohr Effect):

  • An increase in proton concentration (decrease in pH below physiological $7.4$) leads to protonation of specific amino acid residues (e.g., histidine/imidazole groups) on hemoglobin.

  • Protonation stabilizes additional salt bridges that lock hemoglobin into the low-affinity T state.

  • Stabilization of the T state induces a right-shift in the oxygen-binding curve (lowering overall affinity).

  • In rapidly metabolizing tissues (such as exercising skeletal muscle producing lactic acid), elevated proton concentration drives oxygen release, increasing the localized delivery of $O_2$ where metabolic demand is highest.

• Carbon Dioxide Regulation:

  • Active cellular metabolic pathways (glycolysis and fatty acid oxidation) strip carbons from nutrients and produce $CO_2$.

  • Elevated $CO_2$ binds directly to the N-termini of hemoglobin chains to form carbamate derivatives, generating additional negative charges and protons that stabilize the T state.

  • In peripheral tissues, high $CO_2$ forces hemoglobin to shed bound oxygen.

  • In pulmonary capillaries, $CO_2$ dissociates from hemoglobin down its concentration gradient and is exhaled, enabling hemoglobin to transition back to the high-affinity state to load oxygen.

2,3-Bisphosphoglycerate (BPG) and High-Altitude Physiological Adaptation

• Mechanism of 2,3-BPG:

  • 2,3-Bisphosphoglycerate (BPG) is a small, highly charged 3-carbon metabolic intermediate generated inside red blood cells.

  • BPG binds inside the central cavity of hemoglobin present only in the T state, cross-linking the $\beta$-subunits and stabilizing the low-affinity conformation.

• Physiological Adaptation to High Altitude:

  • Sea Level Baseline:

    • Atmospheric pressure provides full oxygenation in lungs ($\approx 98\%$ saturation).

    • Tissue saturation drops to $\approx 60\%$.

    • Net oxygen delivery: $38\%$.

  • Acute High Altitude Exposure ($14,000\text{--}15,000\,\text{ft}$):

    • Lower atmospheric pressure reduces pulmonary oxygen loading down to $\approx 90\%$.

    • Tissue unloading remains at $\approx 60\%$

    • Net oxygen delivery drops sharply to $90\% - 60\% = 30\%$, causing hypoxia and shortness of breath.

  • Acclimatization Response (Hours to Days):

    • Red blood cells synthesize and accumulate elevated concentrations of BPG in the blood.

    • Elevated BPG forces a right-shift of the binding curve (green curve).

    • In the lungs at high altitude, oxygen loading drops slightly further to $\approx 87\%$

    • In the tissues, elevated BPG significantly impairs binding, forcing tissue saturation down to $\approx 50\%$

    • Net oxygen delivery with elevated BPG: $87\% - 50\% = 37\%$, successfully restoring tissue oxygen delivery to near sea-level performance ($38\%$

Carbon Monoxide Toxicity and Intervention

• Carbon Monoxide Binding Properties:

  • Carbon monoxide ($CO$) binds to the heme iron of myoglobin and hemoglobin with an affinity significantly greater than that of oxygen ($O_2$).

  • Binding of $CO$ locks hemoglobin into high-affinity R-state conformations that refuse to release remaining bound oxygen to tissues, causing severe tissue hypoxia.

• Clinical Intervention:

  • $CO$ dissociation from heme is exceptionally slow under ambient conditions.

  • Medical treatment requires immediate administration of high-concentration hyperbaric oxygen via mask to mass-action compete with and displace bound $CO$ from heme sites.

  • Because $CO$ is completely odorless, residential detectors installed near basements and furnaces are vital safety tools to prevent prolonged fatal exposures.

Sickle Cell Anemia: Molecular Pathology and Therapies

• Point Mutation Etiology:

  • Sickle cell anemia results from a single nucleotide substitution changing the $6\text{th}$ amino acid position in the $\beta$-globin polypeptide chain.

  • Glutamate ($\text{E}$, a hydrophilic, negatively charged residue) is mutated to Valine ($\text{V}$, a nonpolar, hydrophobic residue).

• Pathological Aggregation Mechanism:

  • Under deoxy conditions (T state), the mutant Valine residue projects outward from the protein surface.

  • This exposed nonpolar valine fits into a complementary hydrophobic pocket located on a $\beta$-subunit of an adjacent deoxyhemoglobin tetramer.

  • Hydrophobic interactions drive the polymerization of deoxyhemoglobin tetramers into rigid, insoluble fibrous chains.

  • These long fibrous aggregates distort the flexible biconcave shape of red blood cells into rigid, crescent/sickle geometries.

• Clinical Triggers and RBC Turnover:

  • Sickling events are precipitated by physiological conditions that increase the deoxyhemoglobin fraction, including high altitude, intense exercise, dehydration, and systemic illness.

  • Sickled red blood cells fail to pass smoothly through narrow capillary beds, causing painful vaso-occlusive crises.

  • Red blood cells undergo physiological clearance and body turnover every $2$ to $3$ weeks, allowing damaged sickled cells to be cleared and replaced.

• Gene Editing Therapies:

  • CRISPR/Cas9 gene-editing technologies have been developed to treat sickle cell disease.

  • Therapeutic editing targets genetic mechanisms that naturally silence fetal hemoglobin expression after birth.

  • Reactivating fetal hemoglobin ($\gamma$-chains) replaces defective adult $\beta$-chains, preventing pathological aggregation and completely resolving clinical sickling symptoms.

Comparative Immunological Ligand Binding

• Antibody-Antigen Binding Dynamics:

  • Immune system antibodies represent another class of specialized ligand-binding proteins.

  • Different antibody classes feature varying numbers of antigen-binding sites (ranging from divalent monomers to multivalent complexes).

  • Antibody function relies on the fundamental thermodynamic principles of binding affinity, structural specificity, and allosteric conformational regulation.